更年期市場：治療、製品タイプ、適応症、流通課題別-2025～2030年の世界予測

更年期に関する市場は、2023年に177億9,000万米ドルと評価され、2024年には189億9,000万米ドルに達すると予測され、CAGR 6.85％で成長し、2030年には282億9,000万米ドルに達すると予測されています。

女性の生殖期の終わりを示す生物学的な自然な移行である更年期は、生理学的な重大な変化を伴うため、医薬品からライフスタイルやウェルネス製品に至るまで、様々なセグメントにわたってその意味を理解するための包括的な市場調査が必要です。更年期関連製品の必要性は、ほてり、気分の変化、骨粗鬆症などの症状を経験する高齢化した女性が世界的に増加していることから生じ、医療、パーソナルケア、栄養セグメントの需要を牽引しています。主要用途は、ホルモン補充療法（HRT）、非ホルモン治療、サプリメント、症状緩和を目的としたライフスタイル製品などです。エンドユーザーは医療プロバイダーから市販品を購入する消費者まで幅広いです。市場の成長は、意識の高まり、医療支出の増加、技術や製品配合の進歩といった要因に影響されます。パーソナライズド・ヘルスや統合医療への社会的シフトは、特にオーダーメイドのソリューションや遠隔コンサルティングを提供するデジタルヘルスプラットフォームに新たな機会をもたらします。クリーンラベルやサステイナブル製品を求める動向を反映し、天然材料やオーガニック製品の開発にも機会が広がっています。症状の追跡・管理用アプリを開発するためのハイテク企業との戦略的提携も有益です。しかし、規制のハードル、更年期に関連するスティグマ、一部の消費者を躊躇させる可能性のある従来の治療法の潜在的な副作用などの課題も残っています。また、国ごとに異なる規制の複雑さも、市場の成長を妨げる可能性があります。イノベーションは、植物ベースの療法やAIを活用した健康管理ツールなど、副作用なしに症状に対処する、臨床的に検証された非侵襲的ソリューションの開発に焦点を当てるべきです。更年期がメンタルヘルスに与える影響を緩和するための調査や、より効果的な治療のためのバイオテクノロジーの利用は、大きな利益をもたらす可能性があります。全体として、更年期市場は進化しており、技術的進歩や消費者教育による成長の余地が大きいが、可能性を最大化するには規制状況や文化的認識をうまく利用する必要があります。

市場力学：急速に進化する更年期市場の主要市場洞察を公開

更年期市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血管運動症状とその他の更年期症状の高い有病率
  • 健康に対する意識の高まり
  • 治療のための新薬承認数の増加
• 市場抑制要因
  • ホルモン剤に伴う副作用とジェネリック医薬品の利用可能性
• 市場機会
  • 更年期に対するハーブ治療の普及
  • 栄養補助食品の利点を裏付ける調査の増加
• 市場課題
  • 発展途上国における先進的医療インフラの欠如

ポーターのファイブフォース：更年期市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：更年期市場における外部からの影響の把握

外部マクロ環境要因は、更年期市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：更年期市場における競合情勢の把握

更年期市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：更年期市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、更年期市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：更年期市場における成功への道筋を描く

更年期市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血管運動症状やその他の更年期症状の有病率が高い
    • 更年期健康に関する意識の高まり
    • 治療のための新薬承認数の増加
  • 抑制要因
    • ホルモン剤に伴う副作用とジェネリック医薬品の入手可能性
  • 機会
    • 更年期のハーブ治療の普及率
    • 栄養補助食品の利点を裏付ける調査の増加
  • 課題
    • 発展途上国における先進的医療インフラの欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 更年期市場：治療別

• イントロダクション
• 栄養補助食品
• 市販薬
  • ホルモン製品
    • エストロゲンと他の薬剤の併用
    • エストロゲンとプロゲスチンの併用薬
    • エストロゲンのみの薬
    • プロゲスチンのみの薬
  • 非ホルモン製品

第7章 更年期市場：製品タイプ別

• イントロダクション
• ゲル
• 注射
• 経口投与量
• パッチ
• ピル
• 粉末
• スキンクリーム
• スキンスプレー（経皮）
• 膣クリーム
• 膣リング

第8章 更年期市場：適応症別

• イントロダクション
• ドライアイ
• 乾燥肌
• ほてり
• 気分のむら、軽いうつ、イライラ
• 寝汗と寒気
• 骨粗鬆症
• 睡眠障害
• 尿意切迫感
• 膣の乾燥

第9章 更年期市場：流通課題別

• イントロダクション
• 病院薬局
• オンラインストア
• 小売薬局

第10章 南北アメリカの更年期市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の更年期市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの更年期市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbvie Inc.
• Apotex Inc.
• Astellas Pharma Inc.
• Bayer AG
• Cipla Inc.
• Eli Lilly and Company
• Fervent Pharmaceuticals, LLC
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Ltd.
• Merck & Co.Inc.
• Mithra Pharmaceuticals
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• TherapeuticsMD Inc.

LIST OF FIGURES

• FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
• FIGURE 2. MENOPAUSE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MENOPAUSE MARKET DYNAMICS
• TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND OTHER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND PROGESTIN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTIN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY ORAL DOSAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY SKIN CREAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY SKIN SPRAY (TRANSDERMAL), BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL CREAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY DRY EYES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY DRY SKIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY MOOD SWINGS, MILD DEPRESSION & IRRITABILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY NIGHT SWEATS AND COLD FLASHES., BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY TROUBLE SLEEPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL MENOPAUSE MARKET SIZE, BY URINARY URGENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL DRYNESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 62. CANADA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 63. CANADA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 64. CANADA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CANADA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 95. CHINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 96. CHINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. CHINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 100. INDIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 101. INDIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 102. INDIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. INDIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 124. PHILIPPINES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 125. PHILIPPINES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 126. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 130. SINGAPORE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. SINGAPORE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 132. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 133. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH KOREA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 137. SOUTH KOREA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 138. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 139. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH KOREA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 142. TAIWAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 143. TAIWAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 144. TAIWAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. TAIWAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. TAIWAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 148. THAILAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 149. THAILAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 150. THAILAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 151. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. THAILAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 154. VIETNAM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 155. VIETNAM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 156. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 157. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. VIETNAM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 167. DENMARK MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 168. DENMARK MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 169. DENMARK MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 170. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. DENMARK MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 173. EGYPT MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 174. EGYPT MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 175. EGYPT MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 176. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. EGYPT MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 178. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 179. FINLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 180. FINLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 181. FINLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 182. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. FINLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 185. FRANCE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 186. FRANCE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 187. FRANCE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 188. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. FRANCE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 191. GERMANY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 192. GERMANY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 193. GERMANY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 194. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. GERMANY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 196. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 197. ISRAEL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 198. ISRAEL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 199. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 200. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. ISRAEL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 202. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 203. ITALY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 204. ITALY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 205. ITALY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 206. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. ITALY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 208. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 209. NETHERLANDS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 210. NETHERLANDS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 211. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 212. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. NETHERLANDS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 215. NIGERIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 216. NIGERIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 217. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 218. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. NIGERIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 220. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 221. NORWAY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 222. NORWAY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 223. NORWAY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 224. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. NORWAY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 226. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 227. POLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 228. POLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 229. POLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 230. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. POLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 232. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 233. QATAR MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 234. QATAR MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 235. QATAR MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 236. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 237. QATAR MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 238. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 239. RUSSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 240. RUSSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 241. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 242. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 243. RUSSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 244. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 246. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 247. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 248. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 250. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 252. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 253. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 254. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 256. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 257. SPAIN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 258. SPAIN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 259. SPAIN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 260. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 261. SPAIN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 262. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 263. SWEDEN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 264. SWEDEN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 265. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 266. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 267. SWEDEN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 268. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 269. SWITZERLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 270. SWITZERLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 271. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 272. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 273. SWITZERLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 274. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 275. TURKEY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 276. TURKEY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 277. TURKEY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 278. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 279. TURKEY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 280. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 282. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 283. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 284. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 285. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 286. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 288. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 289. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 290. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 291. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 292. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
• TABLE 293. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 294. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023

The Menopause Market was valued at USD 17.79 billion in 2023, expected to reach USD 18.99 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 28.29 billion by 2030.

Menopause, a natural biological transition marking the end of a woman's reproductive years, involves significant physiological changes, necessitating comprehensive market research to understand its implications across various sectors, from pharmaceuticals to lifestyle and wellness products. The necessity for menopause-related products arises from the increasing global population of aging women experiencing symptoms such as hot flashes, mood changes, and osteoporosis, thereby driving demand in healthcare, personal care, and nutritional sectors. The primary applications encompass hormone replacement therapies (HRT), non-hormonal treatments, supplements, and lifestyle products aimed at alleviating symptoms. End-users range from healthcare providers to consumers purchasing over-the-counter products. Market growth is influenced by factors such as growing awareness, increased healthcare spending, and advancements in technology and product formulations. Societal shifts toward personalized health and integrative medicine provide new opportunities, especially in digital health platforms that offer tailored solutions and remote consultations. Opportunities extend to the development of natural and organic offerings, reflecting trends toward clean label and sustainable products. Strategic partnerships with tech firms to develop apps for symptom tracking and management can also be beneficial. However, challenges persist, including regulatory hurdles, the stigma associated with menopause, and potential side effects of conventional therapies, which may deter some consumers. The complexity of differing national regulations can also impede market growth. Innovation should focus on the development of clinically validated, non-invasive solutions that address symptoms without adverse effects, such as plant-based therapies and AI-powered health management tools. Research into mitigating menopause's impact on mental health and the use of biotech for more effective treatments could offer substantial gains. Overall, the menopause market is evolving, with significant scope for growth through technological advancement and consumer education, yet requires navigation of regulatory landscapes and cultural perceptions to maximize potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Menopause Market

The Menopause Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of vasomotor and other menopausal symptoms
  • Rising awareness regarding menopause health
  • Increasing number of new drug approvals for the treatment
• Market Restraints
  • Side effects associated with hormonal products and the availability of generic medicines
• Market Opportunities
  • Prevalence of herbal treatment for menopause
  • Increasing research supporting the advantages of dietary supplements
• Market Challenges
  • Lack of advanced healthcare infrastructure in developing nations

Porter's Five Forces: A Strategic Tool for Navigating the Menopause Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Menopause Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Menopause Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Menopause Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Menopause Market

A detailed market share analysis in the Menopause Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Menopause Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Menopause Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Menopause Market

A strategic analysis of the Menopause Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Menopause Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co.Inc., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc..

Market Segmentation & Coverage

This research report categorizes the Menopause Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Dietary Supplements and OTC Pharma Products. The OTC Pharma Products is further studied across Hormonal products and Non-hormonal products. The Hormonal products is further studied across Combination Estrogen and Other Medicines, Combination Estrogen and Progestin Medicines, Estrogen-Only Medicines, and Progestin-Only Medicines.
• Based on Product Type, market is studied across Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream, and Vaginal Ring.
• Based on Indication, market is studied across Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency, and Vaginal Dryness.
• Based on Distribution Challenge, market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
    • 5.1.1.2. Rising awareness regarding menopause health
    • 5.1.1.3. Increasing number of new drug approvals for the treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
  • 5.1.3. Opportunities
    • 5.1.3.1. Prevalence of herbal treatment for menopause
    • 5.1.3.2. Increasing research supporting the advantages of dietary supplements
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Menopause Market, by Treatment

• 6.1. Introduction
• 6.2. Dietary Supplements
• 6.3. OTC Pharma Products
  • 6.3.1. Hormonal products
    • 6.3.1.1. Combination Estrogen and Other Medicines
    • 6.3.1.2. Combination Estrogen and Progestin Medicines
    • 6.3.1.3. Estrogen-Only Medicines
    • 6.3.1.4. Progestin-Only Medicines
  • 6.3.2. Non-hormonal products

7. Menopause Market, by Product Type

• 7.1. Introduction
• 7.2. Gel
• 7.3. Injection
• 7.4. Oral Dosage
• 7.5. Patch
• 7.6. Pill
• 7.7. Powder
• 7.8. Skin Cream
• 7.9. Skin Spray (Transdermal)
• 7.10. Vaginal Cream
• 7.11. Vaginal Ring

8. Menopause Market, by Indication

• 8.1. Introduction
• 8.2. Dry Eyes
• 8.3. Dry Skin
• 8.4. Hot Flashes
• 8.5. Mood Swings, Mild depression & Irritability
• 8.6. Night Sweats and Cold Flashes.
• 8.7. Osteoporosis
• 8.8. Trouble Sleeping
• 8.9. Urinary Urgency
• 8.10. Vaginal Dryness

9. Menopause Market, by Distribution Challenge

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Stores
• 9.4. Retail Pharmacies

10. Americas Menopause Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Menopause Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Menopause Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbvie Inc.
• 2. Apotex Inc.
• 3. Astellas Pharma Inc.
• 4. Bayer AG
• 5. Cipla Inc.
• 6. Eli Lilly and Company
• 7. Fervent Pharmaceuticals, LLC
• 8. GlaxoSmithKline plc
• 9. Glenmark Pharmaceuticals Ltd.
• 10. Merck & Co.Inc.
• 11. Mithra Pharmaceuticals
• 12. Novartis AG
• 13. Pfizer Inc.
• 14. Teva Pharmaceutical Industries Ltd.
• 15. TherapeuticsMD Inc.